30 Apr 2025 (27 Days) Date | | 1.95 Cons. EPS | - EPS |
11 Feb 2025 Date | | 2.15 Cons. EPS | 2.24 EPS |
5 Nov 2024 Date | | 2.73 Cons. EPS | - EPS |
29 Oct 2024 Date | | 2.73 Cons. EPS | 2.5 EPS |
6 Aug 2024 Date | | 2.54 Cons. EPS | 2.5 EPS |
30 Apr 2025 (27 Days) Date | | 1.95 Cons. EPS | - EPS |
11 Feb 2025 Date | | 2.15 Cons. EPS | 2.24 EPS |
5 Nov 2024 Date | | 2.73 Cons. EPS | - EPS |
29 Oct 2024 Date | | 2.73 Cons. EPS | 2.5 EPS |
6 Aug 2024 Date | | 2.54 Cons. EPS | 2.5 EPS |
Medical Care Facilities Industry | Healthcare Sector | Mr. Javier J. Rodriguez CEO | NYSE Exchange | US23918K1088 ISIN |
US Country | 70,000 Employees | - Last Dividend | 9 Sep 2013 Last Split | 31 Oct 1995 IPO Date |
DaVita Inc. is a leading healthcare provider specializing in kidney dialysis services for patients grappling with chronic kidney failure across the United States. Initially known as DaVita HealthCare Partners Inc., the company underwent a rebranding to DaVita Inc. in September 2016. Since its establishment in 1994, DaVita has been committed to delivering exceptional care and support to patients with end-stage renal disease (ESRD). With its headquarters located in Denver, Colorado, DaVita operates an extensive network of kidney dialysis centers, complemented by various outpatient and inpatient services designed to cater to the comprehensive needs of individuals undergoing dialysis treatment.
DaVita provides essential dialysis treatment in its outpatient centers, ensuring patients receive the necessary care without the need for hospital admission. These services cater to the routine management of kidney failure.
For patients who are hospitalized and cannot visit an outpatient center, DaVita offers in-hospital hemodialysis. This ensures continuity of care even during acute medical conditions.
Understanding the need for comfort and convenience, DaVita supports home-based dialysis treatments. This option empowers patients to manage their condition in the familiar surroundings of their homes.
Operational clinical laboratories provide routine and physician-prescribed laboratory tests specifically designed for ESRD patients, ensuring comprehensive monitoring and management of their condition.
DaVita offers extensive management and administrative support to outpatient dialysis centers, encompassing both company-operated and partnered facilities to ensure they operate efficiently and deliver high-quality care.
In certain risk-based and integrated care arrangements, DaVita extends beyond dialysis by providing coordinated care and disease management services to address the overall health needs of their patients.
Dedicated to advancing knowledge and treatments for kidney disease, DaVita participates in and leads clinical research studies, contributing to the development of innovative care practices.
A comprehensive network of physicians working with DaVita ensures expert medical care and consultation for patients, aiding in the efficient management of kidney disease.
Through a holistic approach, DaVita offers extensive kidney care services, including patient education, nutritional counseling, and support groups, to aid in the overall wellbeing of individuals with kidney disease.
For patients who require more intensive dialysis treatment while hospitalized, DaVita provides acute inpatient dialysis services, ensuring critical care needs are met.
DaVita also engages in the development and maintenance of transplant software, facilitating the management and tracking of kidney transplant processes and patient data.